Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

TransMedics

TransMedics
1998 FOUNDED
PUBLIC STATUS
91-100 EMPLOYEES
TMDX STOCK SYMBOL
$29.61 SHARE PRICE (As of Friday Closing)
Description

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the OCS to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes the technology to replicate near-physiologic conditions for donor organs outside of the human body.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Stock Exchange
NAS
Primary Office
  • 200 Minuteman Road
  • Suite 302
  • Andover, MA 01810
  • United States

+1 (978) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore TransMedics’s full profile, request a free trial.

TransMedics Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$19.76 - $29.80 $599M $28.84 -$1.60 695K 20.2M

TransMedics Financials Summary

In Thousands,
USD
TTM
31-Dec-2018
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Revenue 13,017 13,017 7,685 6,209
EBITDA (20,226) (20,226) (19,089) (22,660)
Net Income (23,756) (23,756) (20,823) (24,065)
Total Assets 42,157 42,157 37,001
Total Debt 33,670 33,670 8,652
Public Fundamental Data provided by Morningstar, Inc. disclaimer

TransMedics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore TransMedics‘s full profile, request access.

Request full access to PitchBook

TransMedics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore TransMedics‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

TransMedics Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Exactech Private Equity-Backed Gainesville, FL 000 000000000000
0000000 Venture Capital-Backed Paris, France 00 0000 0000000000 0000
0000000 Venture Capital-Backed Oxford, United Kingdom 00 000.00 00000000000 000.00
00 000000 Venture Capital-Backed Milpitas, CA 00 00000 0000000000 0 00000
000000 0000000 Formerly VC-backed Audubon, PA 0000 00000 00000000000 00000
To view this company’s complete list of competitors, request access »

TransMedics Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore TransMedics‘s full profile, request access.

Request full access to PitchBook

TransMedics Executive Team (15)

Name Title Board
Seat
Contact
Info
Waleed Hassanein MD Founder, Board Member, President & Chief Executive Officer
Stephen Gordon Chief Financial Officer
Tamer Khayal MD Chief Commercial Officer
Jacqueline Sneve Vice President, Healthcare Economics & Reimbursement
John Sullivan Vice President of Quality & Engineering

8 Former Executives

You’re viewing 5 of 15 executives. Get the full list »

TransMedics Board Members (14)

Name Representing Role Since Contact
Info
Adam Grosser Self Board Member 000 0000
David Abrams Abrams Capital Board Member 000 0000
Earl Collier JD Self Board Member 000 0000
Edward Basile JD Self Board Member 000 0000
Edwin Kania Jr. Flagship Pioneering Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 14 board members. Get the full list »